These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36618976)

  • 1. Deciphering changes in the incidence of the Guillain-Barré syndrome during the COVID-19 pandemic: a nationwide time-series correlation study.
    Lee H; Heo N; Kwon D; Ha J
    BMJ Neurol Open; 2022; 4(2):e000378. PubMed ID: 36618976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Guillain-Barré syndrome in South Korea during the early COVID-19 pandemic.
    Choi SA; Hwang J; Lim BC; Chae SA
    Front Neurol; 2023; 14():1125455. PubMed ID: 36895908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré Syndrome in the COVID-19 Pandemic.
    Tawakul AA; Al-Doboke AW; Altayyar SA; Alsulami SA; Alfahmi AM; Nooh RT
    Neurol Int; 2021 Dec; 14(1):34-48. PubMed ID: 35076589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
    Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.
    Ahmad L; Businaro P; Regalbuto S; Gastaldi M; Zardini E; Panzeri M; Vegezzi E; Fiamingo G; Colombo E; Ravaglia S
    Medicine (Baltimore); 2022 Jul; 101(30):e29704. PubMed ID: 35905215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
    Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
    Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
    García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
    Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome in an era of global infections and 21st century vaccination.
    Lunn MP
    Curr Opin Neurol; 2022 Oct; 35(5):571-578. PubMed ID: 36069416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy).
    Martinelli-Boneschi F; Colombo A; Bresolin N; Sessa M; Bassi P; Grampa G; Magni E; Versino M; Ferrarese C; Zarcone D; Albanese A; Micieli G; Zanferrari C; Cagnana A; Ferrante C; Zilioli A; Locatelli D; Calloni MV; Delodovici ML; Pozzato M; Patisso V; Bortolan F; Foresti C; Frigeni B; Canella S; Xhani R; Crabbio M; Clemenzi A; Mauri M; Beretta S; La Spina I; Bernasconi S; De Santis T; Cavallini A; Ranieri M; D'Adda E; Fruguglietti ME; Peverelli L; Agosti E; Leoni O; Rigamonti A; Salmaggi A
    Neurol Sci; 2023 Feb; 44(2):437-446. PubMed ID: 36289117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series.
    Nagdev G; Chavan G; Sahu G; Devasilpa Raju PD
    Cureus; 2022 Oct; 14(10):e30888. PubMed ID: 36465787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
    Uncini A; Vallat JM; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Guillain-Barré Syndrome and COVID-19 Infection: Experience of a Turkish Neurophysiology Laboratory.
    Durmaz ŞE; Kaya BU; Gümüşyayla Ş
    Noro Psikiyatr Ars; 2022; 59(4):255-259. PubMed ID: 36514509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccine and Guillain-Barré syndrome: A self-controlled case series study.
    Grave C; Boucheron P; Rudant J; Mikaeloff Y; Tubert-Bitter P; Escolano S; Hocine MN; Coste J; Weill A
    Neurology; 2020 May; 94(20):e2168-e2179. PubMed ID: 32098853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
    Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Infectious Guillain-Barré Syndrome Related to SARS-CoV-2 Infection: A Systematic Review.
    Sansone P; Giaccari LG; Aurilio C; Coppolino F; Esposito V; Fiore M; Paladini A; Passavanti MB; Pota V; Pace MC
    Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33670000
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
    Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B;
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
    Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
    Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.